24/7 MARKET NEWS) – PainReform Ltd. (Nasdaq: PRFX) stated, after yesterday’s market close, that it received a letter from The Nasdaq Stock Market notifying the Company that it is eligible for an additional 180 calendar day period, or until August 7, 2023, to regain compliance with the Nasdaq’s minimum $1 bid price per share requirement.
PainReform is at $0.667, up $0.167 (+33.38%), on 5.8 million premarket shares.
Its 52-week trading range is $0.3404 to 1.74. It’s trading above the key $0.65 resistance level and it may challenge its October and September trading levels.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.
